Eighty patients included in this study and undergoing NACT presented invasive ductal carcinoma (100%), most of which were histological grade 3 (51%), ER-positive (71%), and PR-positive (65%). The gene discussed is ESR1; the disease is invasive ductal breast carcinoma.